Ovid Therapeutics Inc.·4

Aug 1, 5:00 PM ET

Rona Jeffrey A 4

4 · Ovid Therapeutics Inc. · Filed Aug 1, 2024

Insider Transaction Report

Form 4
Period: 2024-07-30
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-07-30+315,000315,000 total
    Exercise: $1.04Exp: 2034-07-29Common Stock (315,000 underlying)
Footnotes (1)
  • [F1]50% of the shares subject to the option shall vest on July 30, 2025, and the remaining shares subject to the option shall vest in 12 equal monthly installments thereafter, subject to Reporting Person's continuous service on each such date.

Documents

2 files